A point mutation in exon A (C to G transversion at position 77) of human PTPRC (CD45) has recently been associated with the development of multiple sclerosis (MS) for at least a subgroup of patients. In the present report, we studied the frequency of the 77C-G transversion in two other autoimmune diseases namely systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). The mutation was found with significantly enhanced frequency in patients suffering from SSc suggesting that PTPRC could play a role as susceptibility gene not only in MS but also in other autoimmune diseases. Further understanding of the mode of interaction of mutant PTPRC with other susceptibility genes may uncover mechanisms common in various autoimmune disorders.
The transmembrane protein-tyrosine phosphatase CD45 plays a crucial role in the regulation of various immune responses. 1 The CD45 protein is encoded by a single gene (PTPRC; protein-tyrosine phosphatase, receptor-type C) and different isoforms can be generated by alternative splicing of three variable exons A, B, and C. In humans, a 77C-G mutation in exon A has been described which does not change the protein sequence but prevents proper splicing of the exon thereby leading to a variant expression pattern of CD45RA isoforms on leucocytes. 2, 3 Recent data studying three independent groups of German patients suggest that the exon A mutation could be associated with an enhanced risk for the development of multiple sclerosis (MS). 4 Although subsequent studies failed to detect an association in other MS cohorts 5, 6 data from CD45-manipulated animal models also point to a role of CD45 in the control of autoimmune processes. 7 We therefore assumed that 77C-G in humans may not only be found in MS but also in other autoimmune diseases. To test this hypothesis the frequency of the mutation was determined in 67 patients with systemic sclerosis (SSc) and 98 patients with systemic lupus erythematosus (SLE). Samples obtained from 205 healthy individuals were used as controls.
The 77G allele was detected in five SSc patients and in three out of 205 control individuals (Table 1) . Statistical analysis revealed that the association of the point mutation with SSc is significant (P ¼ 0.029). The mutation was also found in four SLE patients. However, compared to controls the difference was statistically not significant. All individuals carrying the mutation carried it in the heterozygous state. Peripheral blood mononuclear cells (PBMC) from two SLE and one SSc patient with mutant allele could be analyzed by flow cytometry and showed the typical variant CD45RA expression pattern on lymphocytes, monocytes, and granulocytes. 8 This is in line with previous findings suggesting that the point mutation is always associated with defective splicing generating a highly characteristic phenotype in affected individuals 2, 9 The significantly enhanced frequencies of 77C-G in SSc (7.5%; Table 1 ) as well as in MS patients (6-7%) 4 as compared to controls (1.5%) indicate a higher risk for heterozygous carriers to develop SSc or MS. We did not find a significant association of the mutation with SLE. However, the detection of the 77G allele in four out of 98 patients (4.1%; Table 1 ) warrants further studies and is in line with the assumption that PTPRC could play a role as susceptibilty gene in several autoimmune diseases. Abnormal CD45 splicing may also be associated with a higher risk of infection with some organisms since 5.6% of HIV-1 patients have recently been reported to carry the 77C-G mutation. 10 Furthermore, two families with a similar splice defect associated with haemophagocytic lymphohistiocytosis and erythrocytic haemophagocytosis have been described. 11, 12 Susceptibility to systemic lupus erythematosus, or systemic sclerosis is regarded to be determined by multiple genetic factors. 13, 14 As in other complex diseases the number of susceptibility genes and their mode of inheritance are not known in detail yet. One approach to address this question is genome-wide linkage studies to identify the chromosomal position of potential Correspondence: Reinhard Schwinzer, Transplantationslabor, Klinik fü r Viszeral-und Transplantationschirurgie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30623 Hannover, Germany. E-mail: schwinzer.reinhard@mh-hannover.de susceptibility loci with the aim to subsequently identify the relevant gene(s). An alternative approach taken in this study is the analysis of associations with known polymorphisms of genes potentially involved in the pathogenesis of a disease (candidate genes). Although the 77C-G mutation is present in the normal population with a frequency of 1-2% it is obvious that the vast majority of carriers are healthy as the overall prevalence of SSc and SLE is about 10/100 000 and 50/100 000 individuals, respectively, and only 4-8% of the diseased individuals carry the mutation. Thus, the 77C-G polymorphism contributes to disease susceptibility only in the context of additional genetic and possibly also environmental factors.
In individuals carrying 77C-G, CD45RA molecules are strongly expressed on cells which normally express only the low molecular mass CD45R0 isoform (eg memory and activated T cells). Since CD45RA and CD45R0 isoforms differentially influence T-cell receptor as well as cytokine receptor-induced signal transduction 1 it is conceivable that continuous overexpression of CD45RA molecules could change the patterns of immune responsiveness in affected individuals. The aberrant expression pattern of CD45RA molecules might affect signalling mechanisms by (i) altering the binding pattern of CD45 ligands, (ii) disturbing ligand-induced dimerization of CD45 molecules known to be required for proper regulation of their phosphatase activity, or (iii) interfering with processes leading to the exclusion of CD45 molecules from membrane rafts involved in the formation of the immunological synapse. Studying appropriate cell populations from carriers of the mutation will allow to analyse whether such effects can be demonstrated in vitro and in which way they might be related to the development of autoimmune processes.
